$5.5
+0.01
(+0.18%)▲
Revenue is up for the last 2 quarters, 2.09B → 2.09B (in $), with an average increase of 0.3% per quarter
Netprofit is down for the last 3 quarters, 633.0M → 280.0M (in $), with an average decrease of 31.6% per quarter
In the last 1 year, ICL Group Ltd. has experienced a drawdown of -49.2%, however Corteva Inc resisted the overall trend and outperformed by 35.0%
In the last 3 years, Mosaic Company has given 99.4% return, outperforming this stock by 39.3%
2.18%
Downside
Day's Volatility :3.06%
Upside
0.9%
1.27%
Downside
52 Weeks Volatility :47.89%
Upside
47.22%
Period | ICL Israel Chemicals Ltd | Sector (Materials) | Index (Russel 2000) |
---|---|---|---|
3 Months | -23.75% | -9.0% | -6.8% |
6 Months | -33.54% | -9.5% | -6.0% |
1 Year | -49.17% | -11.9% | -4.6% |
3 Years | 60.06% | 34.4% | 25.9% |
Market Capitalization | 7.2B |
Book Value | $4.37 |
Dividend Share | 0.784 |
Dividend Yield | 2.07% |
Earnings Per Share (EPS) | 1.4 |
PE Ratio | 3.93 |
PEG Ratio | 9.44 |
Wall Street Target Price | 7.48 |
Profit Margin | 18.85% |
Operating Margin TTM | 32.2% |
Return On Assets TTM | 16.27% |
Return On Equity TTM | 33.1% |
Revenue TTM | 9.6B |
Revenue Per Share TTM | 7.44 |
Quarterly Revenue Growth YOY | -16.900000000000002% |
Gross Profit TTM | 5.0B |
EBITDA | 3.5B |
Diluted Eps TTM | 1.4 |
Quarterly Earnings Growth YOY | -0.56 |
EPS Estimate Current Year | 0.83 |
EPS Estimate Next Year | 0.71 |
EPS Estimate Current Quarter | 0.21 |
EPS Estimate Next Quarter | 0.26 |
What analysts predicted
Upside of 36.0%
FY17 | Y/Y Change | |
---|---|---|
Revenue | 5.4B | ↑ 1.03% |
Net Income | 364.0M | ↓ 398.36% |
Net Profit Margin | 6.72% | ↑ 8.99% |
FY18 | Y/Y Change | |
---|---|---|
Revenue | 5.6B | ↑ 2.55% |
Net Income | 1.2B | ↑ 240.66% |
Net Profit Margin | 22.32% | ↑ 15.6% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 5.3B | ↓ 5.13% |
Net Income | 475.0M | ↓ 61.69% |
Net Profit Margin | 9.01% | ↓ 13.31% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 5.0B | ↓ 4.33% |
Net Income | 11.0M | ↓ 97.68% |
Net Profit Margin | 0.22% | ↓ 8.79% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 7.0B | ↑ 37.91% |
Net Income | 783.0M | ↑ 7018.18% |
Net Profit Margin | 11.26% | ↑ 11.04% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 10.0B | ↑ 44.0% |
Net Income | 2.2B | ↑ 175.73% |
Net Profit Margin | 21.56% | ↑ 10.3% |
Q4 FY21 | Q/Q Change | |
---|---|---|
Revenue | 2.0B | ↑ 13.85% |
Net Income | 283.0M | ↑ 25.78% |
Net Profit Margin | 13.89% | ↑ 1.32% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Revenue | 2.5B | ↑ 23.9% |
Net Income | 632.0M | ↑ 123.32% |
Net Profit Margin | 25.03% | ↑ 11.14% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Revenue | 2.9B | ↑ 14.06% |
Net Income | 563.0M | ↓ 10.92% |
Net Profit Margin | 19.55% | ↓ 5.48% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 2.5B | ↓ 12.53% |
Net Income | 633.0M | ↑ 12.43% |
Net Profit Margin | 25.13% | ↑ 5.58% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 2.1B | ↓ 16.99% |
Net Income | 331.0M | ↓ 47.71% |
Net Profit Margin | 15.83% | ↓ 9.3% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 2.1B | ↑ 0.33% |
Net Income | 280.0M | ↓ 15.41% |
Net Profit Margin | 13.35% | ↓ 2.48% |
FY17 | Y/Y Change | |
---|---|---|
Total Assets | 8.7B | ↑ 1.89% |
Total Liabilities | 5.9B | ↓ 2.06% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 8.8B | ↑ 0.71% |
Total Liabilities | 4.9B | ↓ 16.98% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 9.2B | ↑ 4.52% |
Total Liabilities | 5.1B | ↑ 5.16% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 9.7B | ↑ 5.35% |
Total Liabilities | 5.6B | ↑ 9.08% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 11.1B | ↑ 14.65% |
Total Liabilities | 6.3B | ↑ 13.77% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 11.8B | ↑ 6.05% |
Total Liabilities | 6.0B | ↓ 4.84% |
Q4 FY21 | Q/Q Change | |
---|---|---|
Total Assets | 11.1B | ↑ 4.81% |
Total Liabilities | 6.3B | ↑ 4.86% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 11.7B | ↑ 5.27% |
Total Liabilities | 6.3B | ↑ 0.05% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 11.8B | ↑ 0.98% |
Total Liabilities | 6.4B | ↑ 0.55% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 11.6B | ↓ 1.53% |
Total Liabilities | 6.1B | ↓ 5.12% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 11.8B | ↑ 1.31% |
Total Liabilities | 6.0B | ↓ 0.3% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 12.0B | ↑ 2.51% |
Total Liabilities | 6.1B | ↑ 1.82% |
FY17 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 847.0M | ↓ 12.32% |
Investing Cash Flow | -333.0M | ↓ 58.37% |
Financing Cash Flow | -511.0M | ↑ 113.81% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 620.0M | ↓ 26.8% |
Investing Cash Flow | 331.0M | ↓ 199.4% |
Financing Cash Flow | -894.0M | ↑ 74.95% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 992.0M | ↑ 60.0% |
Investing Cash Flow | -525.0M | ↓ 258.61% |
Financing Cash Flow | -490.0M | ↓ 45.19% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 804.0M | ↓ 18.95% |
Investing Cash Flow | -583.0M | ↑ 11.05% |
Financing Cash Flow | -105.0M | ↓ 78.57% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.1B | ↑ 32.46% |
Investing Cash Flow | -579.0M | ↓ 0.69% |
Financing Cash Flow | -244.0M | ↑ 132.38% |
Q4 FY21 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 344.0M | ↑ 26.01% |
Investing Cash Flow | -22.0M | ↓ 92.57% |
Financing Cash Flow | -153.0M | ↓ 7750.0% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 325.0M | ↓ 5.52% |
Investing Cash Flow | -107.0M | ↑ 386.36% |
Financing Cash Flow | -260.0M | ↑ 69.93% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 627.0M | ↑ 92.92% |
Investing Cash Flow | -264.0M | ↑ 146.73% |
Financing Cash Flow | -351.0M | ↑ 35.0% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 606.0M | ↓ 3.35% |
Investing Cash Flow | -176.0M | ↓ 33.33% |
Financing Cash Flow | -337.0M | ↓ 3.99% |
Sell
Neutral
Buy
ICL Israel Chemicals Ltd is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() ICL Israel Chemicals Ltd | -10.15% | -33.54% | -49.17% | 60.06% | 18.06% |
![]() FMC Corp. | -15.9% | -19.96% | -14.49% | 5.26% | 36.23% |
![]() Nutrien Ltd. | -24.55% | -32.92% | -44.19% | 50.27% | 3.82% |
![]() Corteva, Inc. | -12.97% | -19.26% | -14.18% | 99.44% | 84.45% |
![]() CF Industries Holdings, Inc. | -14.51% | -40.65% | -35.6% | 107.87% | 51.99% |
![]() Mosaic Company, The | -26.68% | -34.91% | -45.54% | 155.27% | 15.55% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() ICL Israel Chemicals Ltd | 3.93 | 3.93 | 9.44 | 0.83 | 0.33 | 0.16 | 0.02 | 4.37 |
![]() FMC Corp. | 16.13 | 16.13 | 1.85 | 7.74 | 0.25 | 0.07 | 0.02 | 27.76 |
![]() Nutrien Ltd. | 4.24 | 4.24 | NA | 6.8 | 0.28 | 0.1 | 0.04 | 50.92 |
![]() Corteva, Inc. | 32.34 | 32.34 | 1.31 | 2.97 | 0.05 | 0.03 | 0.01 | 36.02 |
![]() CF Industries Holdings, Inc. | 4.13 | 4.13 | 0.64 | 9.23 | 0.48 | 0.22 | 0.03 | 27.98 |
![]() Mosaic Company, The | 4.09 | 4.09 | 0.2 | 5.3 | 0.24 | 0.11 | 0.02 | 35.81 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() ICL Israel Chemicals Ltd | Hold | $7.2B | 18.06% | 3.93 | 18.85% |
![]() FMC Corp. | Buy | $13.0B | 36.23% | 16.13 | 12.51% |
![]() Nutrien Ltd. | Buy | $27.0B | 3.82% | 4.24 | 19.32% |
![]() Corteva, Inc. | Buy | $39.2B | 84.45% | 32.34 | 6.64% |
![]() CF Industries Holdings, Inc. | Buy | $12.1B | 51.99% | 4.13 | 29.26% |
![]() Mosaic Company, The | Hold | $11.1B | 15.55% | 4.09 | 15.08% |
Goldman Sachs Group Inc
Achmea Investment Management B.V.
SIMPLEX TRADING, LLC
Ativo Capital Management LLC
In the quarter ending September,2023. ICL Israel Chemicals Ltd has declared dividend of $0.11
Read MoreICL Group Ltd. is a multi-national manufacturing concern that develops, produces and markets fertilizers, metals and other special-purpose chemical products. ICL serves primarily three markets: agriculture, food and engineered materials.
Organization | ICL Israel Chemicals Ltd |
Employees | 12500 |
CEO | Mr. Raviv Zoller |
Industry | Process Industries |
NiSource Inc.
$26.67
-0.82%
ISHARES GSCI COMMODITY DYNAM
$25.49
+1.88%
ALPHA CAPITAL HOLDCO CO-A
$2.16
-3.57%
SPDR Portfolio Large Cap ETF
$49.58
+0.9%
Fortune Brands Innovations, Inc.
$61.27
+1.36%
ESGEN ACQUISITION CORP.
$10.86
+0.0%
NuShares ESG Mid-Cap Value ETF
$27.65
+0.47%
PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF
$17.98
+1.13%
BLACKROCK MUNIVEST FUND
$6.67
+0.6%